Article Text

Download PDFPDF

The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics
  1. Yongjun Wang1,2,3,4,
  2. Jing Jing1,2,3,4,
  3. Xia Meng1,2,3,4,
  4. Yuesong Pan1,2,3,4,
  5. Yilong Wang1,2,3,4,
  6. Xingquan Zhao1,2,3,4,
  7. Jinxi Lin1,2,3,4,
  8. Wei Li1,2,3,4,
  9. Yong Jiang1,2,3,4,
  10. Zixiao Li1,2,3,4,
  11. Xinmiao Zhang1,2,3,4,
  12. Xiaomeng Yang1,2,3,4,
  13. Ruijun Ji1,2,3,4,
  14. Chunjuan Wang1,2,3,4,
  15. Zhimin Wang5,
  16. Xinsheng Han6,
  17. Songdi Wu7,
  18. Zhengchang Jia8,
  19. Yongming Chen9,
  20. Hao Li1,2,3,4
  1. 1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
  2. 2 China National Clinical Research Center for Neurological Diseases, Beijing, China
  3. 3 Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China
  4. 4 Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
  5. 5 Department of Neurology, The First people’s Hospital of Taizhou, Taizhou, China
  6. 6 Department of Neurology, The Kaifeng Central Hospital, Kaifeng, China
  7. 7 Department of Neurology, The First People’s Hospital of Xi’an, Xi’an, China
  8. 8 Department of Neurology, The Second People’s Hospital of Jinzhong, Jinzhong, China
  9. 9 Department of Neurology, WuYuan County People’s Hospital, Bayannur, China
  1. Correspondence to Dr Yongjun Wang; yongjunwang{at}ncrcnd.org.cn

Footnotes

  • Contributor YoW had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: YoW, JJ, XM, YiW and RJ. Supplying patients: ZW, XH, SW, ZJ and YC. Drafting of the manuscript: YoW, YP and HL. Critical revision of the manuscript for important intellectual content: YiW, XZ and HL. Statistical analysis: YP, HL and YJ. Study supervision and organisation of the project: YoW, XM, JL, WL, ZL, XZ, XY and CW.

  • Funding This study was supported by grants from the Ministry of Science and Technology of the People’s Republic of China (2016YFC0901001, 2016YFC0901002, 2017YFC1310901, 2017YFC1310902, 2018YFC1311700 and 2018YFC1311706), and grants from Beijing Municipal Commission of Health and Family Planning (No.2016-1-2041, SML20150502).

  • Competing interests None declared.

  • Ethics approval The protocol of the CNSR-III study was approved by ethics committee at Beijing Tiantan Hospital (IRB approval number: KY2015-001-01) and all participating centres.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributor YoW had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: YoW, JJ, XM, YiW and RJ. Supplying patients: ZW, XH, SW, ZJ and YC. Drafting of the manuscript: YoW, YP and HL. Critical revision of the manuscript for important intellectual content: YiW, XZ and HL. Statistical analysis: YP, HL and YJ. Study supervision and organisation of the project: YoW, XM, JL, WL, ZL, XZ, XY and CW.

  • Funding This study was supported by grants from the Ministry of Science and Technology of the People’s Republic of China (2016YFC0901001, 2016YFC0901002, 2017YFC1310901, 2017YFC1310902, 2018YFC1311700 and 2018YFC1311706), and grants from Beijing Municipal Commission of Health and Family Planning (No.2016-1-2041, SML20150502).

  • Competing interests None declared.

  • Ethics approval The protocol of the CNSR-III study was approved by ethics committee at Beijing Tiantan Hospital (IRB approval number: KY2015-001-01) and all participating centres.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.